Expand OMER Menu
OMER MENU

OMER Latest Press Releases

-- July 23, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER PRNewswire 10:01 AM

-- July 21, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Omeros Corporation - OMER Globe Newswire 12:56 PM

-- July 9, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER PRNewswire 7:57 PM

-- July 8, 2026 --

OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm Globe Newswire 9:34 AM

-- July 7, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER Globe Newswire 5:47 PM

-- July 6, 2026 --

OMER Investors Have Opportunity to Join Omeros Corporation Fraud Investigation with the Schall Law Firm Business Wire 7:57 PM

-- July 1, 2026 --

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Omeros Corporation - OMER PRNewswire 8:12 PM

-- June 26, 2026 --

Omeros Corporation Announces Update on European Marketing Authorization Application for Narsoplimab in TA-TMA Business Wire 8:30 AM

-- June 15, 2026 --

Omeros Announces Webcast Details for Annual Meeting of Shareholders Business Wire 8:30 AM

-- May 13, 2026 --

Omeros Corporation Reports First Quarter 2026 Financial Results Business Wire 4:02 PM

-- May 11, 2026 --

Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026 Business Wire 4:02 PM

-- April 20, 2026 --

Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer Globe Newswire 7:00 AM

-- April 16, 2026 --

CMS Assigns Permanent Reimbursement J-Code for YARTEMLEA (narsoplimab-wuug) Business Wire 8:45 AM

-- March 31, 2026 --

Omeros Corporation Reports Fourth Quarter and Year-End 2025 Financial Results Business Wire 4:02 PM

-- March 26, 2026 --

Omeros Corporation to Announce Fourth Quarter and Full-Year 2025 Financial Results on March 31, 2026 Business Wire 8:45 AM

-- March 21, 2026 --

Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment Business Wire 3:23 AM
Market Data Delayed 15 Minutes